{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:32:34Z","timestamp":1789605154407,"version":"build-2803163510"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nephrol."],"abstract":"<jats:p>Tertiary hyperparathyroidism (THPT) is a severe complication of uncontrolled secondary hyperparathyroidism, typically associated with advanced-stage chronic kidney disease (CKD). We present the case of a Honduran patient with a long-standing history of CKD secondary to severe preeclampsia, who developed THPT following the discontinuation of her treatment due to financial constraints and the COVID-19 pandemic. The patient exhibited severe maxillofacial deformities, functional limitations, and widespread skeletal abnormalities. Despite initial management with medications such as paricalcitol and alfacalcidol, the lack of access to appropriate therapies and the postponement of a planned parathyroidectomy worsened her condition. This case highlights the importance of early diagnosis and timely intervention, particularly in resource-limited settings, emphasizing the urgent need for kidney transplant programs and improved preventive strategies in developing countries.<\/jats:p>","DOI":"10.3389\/fneph.2025.1645622","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T04:10:38Z","timestamp":1756699838000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Severe consequences of uncontrolled tertiary hyperparathyroidism in a limited resources setting: a case report"],"prefix":"10.3389","volume":"5","author":[{"given":"Beatriz","family":"Mej\u00eda Raudales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Andres","family":"Portillo Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genesis Sarahi","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simmons","family":"Gough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.7417\/CT.2021.2322","article-title":"Tertiary hyperparathyroidism: A Review","volume":"172","author":"Palumbo","year":"2021","journal-title":"US Natl Library Med"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.1159\/000491041","article-title":"91 - 108: Secondary and tertiary hyperparathyroidism","author":"Mesa","year":"2019","journal-title":"Front Hormone Res"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.88","article-title":"Chronic kidney disease","volume":"3","author":"Romagnani","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B4","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000514550","article-title":"Global Epidemiology of end-stage kidney disease and disparities in kidney replacement therapy","volume":"52","author":"Thurlow","year":"2021","journal-title":"Am J Nephrol"},{"key":"B5","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/1457496919866015","article-title":"Secondary and tertiary hyperparathyroidism: A narrative review","volume":"109","author":"Van der Plas","year":"2019","journal-title":"Scandinav J Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.389430","article-title":"Uremic leontiasis ossea: Theoretical concepts and practical considerations","volume":"33","author":"Sabanis","year":"2022","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"Care guidelines for case reports: Explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1016\/S1132-8460(09)73461-0","article-title":"Cl\u00ednica y diagn\u00f3stico diferencial de los hiperparatiroidismos","volume":"18","author":"Gilsanz Fern\u00e1ndez","year":"2009","journal-title":"Revista Espa\u00f1ola de Enfermedades Metab\u00f3licas \u00d3seas"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e2248332","DOI":"10.1001\/jamanetworkopen.2022.48332","article-title":"Analysis of time to diagnosis and outcomes among adults with primary hyperparathyroidism","volume":"5","author":"Lorenz","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab184","article-title":"Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort","volume":"37","author":"Bozic","year":"2022","journal-title":"Nephrol Dialysis Transplant"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.26820\/recimundo\/4.(4).octubre.2020.282-290","article-title":"Hiperparatiroidismo secundario insuficiencia renal","volume":"4","author":"Moreta Colcha","year":"2020","journal-title":"Recimundo"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2020.02.002","article-title":"Brown tumors of the oral cavity: Presentation of 4 new cases and a systematic literature review","volume":"129","author":"Lajolo","year":"2020","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000444703","article-title":"Brown tumors: A case report and review of the literature","volume":"6","author":"Can","year":"2016","journal-title":"Case Rep Nephrol Dialysis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.139.9.974","article-title":"Tertiary hyperparathyroidism: histologic patterns of disease and results of parathyroidectomy","volume":"139","author":"Kebebew","year":"2004","journal-title":"Arch Surg"},{"key":"B16","article-title":"The face of Sagliker\u2019s syndrome in maxillofacial aspect: a brief review","volume":"12","author":"Bansod","year":"","journal-title":"Int J Clin Trials"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13854","article-title":"Clinical factors associated with early and persistent hypocalcaemia after parathyroidectomy in patients on dialysis with severe hyperparathyroidism","volume":"26","author":"Fonseca-Correa","year":"2021","journal-title":"Nephrology"}],"container-title":["Frontiers in Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2025.1645622\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T04:10:39Z","timestamp":1756699839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2025.1645622\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":17,"alternative-id":["10.3389\/fneph.2025.1645622"],"URL":"https:\/\/doi.org\/10.3389\/fneph.2025.1645622","relation":{},"ISSN":["2813-0626"],"issn-type":[{"value":"2813-0626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"article-number":"1645622"}}